tiprankstipranks

Colin Broom Insider Profile

4 Followers
Colin Broom, Director at NPS Pharma, holds 36.52K shares in Nabriva Therapeutics (Ticker: NBRVF), holds 0.00 shares in NPS Pharma (Ticker: NPSP), holds 0.00 shares in Viropharma (Ticker: VPHM). Most recently, Colin Broom Sold ― shares of Nabriva Therapeutics on Aug 04, 2022 for an estimated value of 1.01K.
tipranks
Colin Broom

Colin Broom
NPS Pharma (NPSP)
Director

Ranked #70,567 out of 98,743 Corporate Insiders

Profitable Transactions

33%
2 out of 6 Profitable Transactions

Average Return

-11.40%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$5K
100.00%
A breakdown of Colin Broom's holdings

Insider Roles

Nabriva Therapeutics
(NBRVF)
Director
Roles that Colin Broom holds in companies

Most Profitable Insider Trade

Stock:
Nabriva Therapeutics
(NBRVF)
Rating:Informative Sell
Date:Aug 04, 2021 - Aug 04, 2022
Return:+85.00%
The most profitable trade made by Colin Broom

Colin Broom's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
NPSP
NPS Pharma
Feb 24, 2015
Uninformative Sell
1.12M
Nabriva Therapeutics
Aug 04, 2022
Director
Informative Sell
1.01K
$4.75K
VPHM
Viropharma
Jan 28, 2014
Uninformative Buy
List of latest transactions for each holding click on a transaction to see Colin Broom's performance on stock

Colin Broom insider profile FAQ

What is the percentage of profitable transactions made by Colin Broom?
The percentage of profitable transactions made by Colin Broom is 33%.
    What is the average return per transaction made by Colin Broom?
    The average return per transaction made by Colin Broom is -11.40%.
      What stocks does Colin Broom hold?
      Colin Broom holds: NPSP, NBRVF, VPHM stocks.
        What was Colin Broom’s latest transaction?
        Colin Broom latest transaction was an Informative Sell of $1.01K.
          What was Colin Broom's most profitable transaction?
          Colin Broom’s most profitable transaction was an Informative Sell of NBRVF stock on August 4, 2021. The return on the trade was 85.00%.
            What is Colin Broom's role in NPS Pharma?
            Colin Broom's role in NPS Pharma is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.